We hypothesize that AF progression can be best limited by inhibiting this fundamental phenotypic change early in the process before irreversible changes occur. CAREBANK enables the identification of patients in sinus rhythm at baseline who will later encounter new-onset AF. By carefully overlaying transcriptomic, proteomic and histopathologic data, we narrow down the potential druggable targets and mechanistically test them using zebrafish models.
Kiviniemi TO, Kc A, Chiang DY, Teramoto R, Buys E, Kelly AE, George WA, Ghazizadeh Z, Relander A, Gunn J, Hollmén M, Beerens M, MacRae CA.
cell polarity abnormalities characterize the prearrhythmic substrate for atrial fibrillation
Submitted
Ghazizadeh Z, Kiviniemi TO, Olafsson S, Plotnick D, Beerens M, Zhang K, Gillon L, Steinbaugh M, Barrera V, Ho Sui S, Werdich AA, Kapur S, Eranti A, Gunn J, Jalkanen J, Airaksinen J, Kleber AG, Hollmén M, MacRae CA.
A METASTABLE ATRIAL STATE UNDERLIES THE PRIMARY GENETIC SUBSTRATE FOR MYL4 MUTATION-ASSOCIATED ATRIAL FIBRILLATION.
Circulation. 2019 Nov 16. doi: 10.1161/CIRCULATIONAHA.119.044268.
Suvi Linna-Kuosmanen, Eloi Schmauch, Kyriakitsa Galani, Carles A. Boix, Lei Hou, Tiit Örd, Anu Toropainen, Lindsey K. Stolze, Elamaran Meibalan, Julio C. Mantero, Ashley Renfro, Johannes Ojanen, Leandro Z. Agudelo, Maija Hollmen, Juho Jalkanen, Jarmo Gunn, Pasi Tavi, Casey E. Romanoski, Calum A. MacRae, Minna U. Kaikkonen, Guillermo Garcia-Cardena, Tuomas Kiviniemi, Manolis Kellis
single-cell dissection of live human hearts in ischemic heart disease and heart failure reveals cell-type-specific drivergenes and pathways
bioRxiv, https://doi.org/10.1101/2021.06.23.449672
Viikinkoski E, Jalkanen J, Gunn J, Vasankari T, Lehto J, Valtonen M, Biancari F, Jalkanen S, Airaksinen KEJ, Hollmén M, Kiviniemi TO.
red blood cell transfusion induces abnormal hif1-a response to cytokine storm after cardiac surgery.
Sci Rep. 2021 Nov 15;11(1):22230. doi: 10.1038/s41598-021-01695-4.
Koskinen A, Aittokallio J, Gunn J, Relander A, Viikinkoski E, Vasankari T, Jalkanen J, Hollmen M, Kiviniemi TO.
disadvantages of high fluid infusion rate in cardiac surgery.
Eur J Anaesthesiol. 2022 Dec 1;39(12):963-966. doi: 10.1097/EJA.0000000000001764